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Oct4 is an essential regulator of pluripotency in vivo
and in vitro in embryonic stem cells, as well as
a keymediator of the reprogramming of somatic cells
into induced pluripotent stem cells. It is not known
whether activation and/or repression of specific
genes by Oct4 is relevant to these functions. Here,
we show that fusion proteins containing the coding
sequence of Oct4 or Xlpou91 (the Xenopus homolog
of Oct4) fused to activating regions, but not those
fused to repressing regions, behave as Oct4, sup-
pressing differentiation and promoting maintenance
of undifferentiated phenotypes in vivo and in vitro.
An Oct4 activation domain fusion supported embry-
onic stem cell self-renewal in vitro at lower concen-
trations than that required for Oct4 while alleviating
the ordinary requirement for the cytokine LIF. At still
lower levels of the fusion, LIF dependence was
restored. We conclude that the necessary and suffi-
cient function of Oct4 in promoting pluripotency is
to activate specific target genes.
INTRODUCTION
Cells that can differentiate into all adult cell types exist transiently
in early embryos. When cultured in vitro, these pluripotent
embryonic stem cells (ESCs) can self-renew indefinitely (Evans
and Kaufman, 1981; Martin, 1981). Pluripotent, self-renewing
cell lines, called induced pluripotent stem cells (iPSCs), can
also be derived from somatic cells by transient ectopic expres-
sion of transcription factors that are normally expressed in
ESCs (Takahashi and Yamanaka, 2006). The pluripotent state
can be maintained in vitro by defined cytokines such as LIF
(Smith et al., 1988; Williams et al., 1988) and BMP4 or serum(Ying et al., 2003) for mouse pluripotent cells. In particular,
removal of LIF leads to spontaneous differentiation of mouse
ESCs toward mesoderm and endoderm (Ying et al., 2003).
The class V Pou (PouV) transcription factor Oct4 is central to
both the generation and the maintenance of iPSCs and ESCs.
Thus, removal of Oct 4 from ESCs causes these cells to differen-
tiate into trophectoderm and primitive endoderm (Hay et al.,
2004; Niwa et al., 1998; Niwa et al., 2000), and of the original
four factors that together enable iPSC formation, (Oct4, Klf4,
Sox2, and c-Myc) (Takahashi and Yamanaka, 2006), only Oct4
is essential regardless of the source of somatic cell (Kim et al.,
2009). In mouse embryos, Oct4 is initially expressed in the inner
cell mass (ICM) of the blastocyst but persists in the pluripotent
epiblast and becomes progressively restricted to the posterior
region of the embryo, where progenitor cells remain throughout
gastrulation (Palmieri et al., 1994). Oct4/ embryos die at preim-
plantation stages as a result of the differentiation of pluripotent
ICM progenitors to trophectoderm (Nichols et al., 1998). Oct4
homologs in nonmammalian species are also expressed in
gastrulation-stage progenitors, where they act to block preco-
cious differentiation (Cao et al., 2006; Lavial et al., 2007; Lunde
et al., 2004; Morrison and Brickman, 2006; Reim et al., 2004).
The Xenopus laevis PouV protein, Xlpou91, can support murine
ESC self-renewal of Oct4 null cells, and Oct4mRNA can rescue
some Xenopus PouV knockdown phenotypes (Morrison and
Brickman, 2006). What gene-regulatory mechanisms are
required to establish and maintain ESCs and iPSCs, and in
particular, what role is played by Oct4?
Despite an abundance of data on Oct4 targets and pheno-
types, it is still unclear how Oct4 acts as a transcription factor
to regulate differentiation. Experiments with reporter genes in
cell lines suggest that Oct4 can function as both an activator
and a repressor of gene transcription (reviewed in Pan et al.,
2002), and Oct4 has been found to be associated with both acti-
vator and repressor complexes (Ang et al., 2011; Bilodeau et al.,
2009; Boyer et al., 2006; Pardo et al., 2010; Pasini et al., 2010;
Yeap et al., 2009; Yuan et al., 2009).Cell Reports 1, 99–109, February 23, 2012 ª2012 The Authors 99
Table 1. PouV Fusion Proteins
Fusion Protein PouV Protein Hinge Transcriptional Regulatory Region Repeats
Oct4lVP2 mOct4 l C1 (91–132) VP16 (413–460) 2
XlPou91lVP2 XlPou91 l C1 (91–132) VP16 (413–460) 2
OCT4-VP16 hOCT4 - VP16 (425–455) 1
OCT4-VP16 hOCT4 - VP16 (425–490) 1
OCT4-VP16 (3F) hOCT4 - VP16 (PADALDDFDLDML) 3
Oct4lEnR mOct4 l C1 (91–132) EnR (168–281) 1
XlPou91lEnR XlPou91 l C1 (91–132) EnR (168–281) 1
OCT4-HP1a hOCT4 - HP1a 1
OCT4-HP1b hOCT4 - HP1b 1
OCT4-HP1g hOCT4 - HP1g 1
The human and mouse Oct4 genes and the Xenopus homolog XlPou91 were variously fused to one or more activating regions from VP16, to a repres-
sing region from theDrosophila Engrailed protein, and to one of each of the three intact isoforms of the human protein HP1. In some cases a sequence
encoding a hinge region in lambda repressor c1 was inserted between Oct4 or XlPou91, added regulatory sequences, and repeated regulatory
modules (Ohashi et al., 1994). PADALDDFDLDML is a single amino acid variant of an activating sequence found in VP16 (Baron et al., 1997). ‘‘Repeats’’
indicate the number of copies of the activation region in the corresponding fusion. The three OCT4-VP16 activation fusions are listed in the order of
their presumed activation strengths, referred to in the text as ‘‘weak,’’ ‘‘medium,’’ and ‘‘strong.’’ Abbreviations are as follows: m, murine; h, human;
Xl, Xenopus laevis.Genome-wide chromatin immunoprecipitation (ChIP) experi-
ments, with both human and mouse ESCs, have detected
Oct4 bound to numerous genes, some of which are expressed
in ESCs and some of which are not (Boyer et al., 2005; Chen
et al., 2008; Kim et al., 2008; Loh et al., 2006). Some of these
genes become upregulated, and some downregulated, as
ESCs differentiate in response to Oct4 knockdown (Sharov
et al., 2008) (Loh et al., 2006). This finding has led to the sugges-
tion that, in ESCs, Oct4/PouV and its partners Sox2 and Nanog
simultaneously activate genes encoding components of a ‘‘plu-
ripotency network’’ and, simultaneously, repress differentia-
tion-specific genes (Bilodeau et al., 2009; Boyer et al., 2005;
Boyer et al., 2006; Chen et al., 2008; Kim et al., 2008; Loh
et al., 2006; Pasini et al., 2010). A contrasting suggestion is
that Oct4 drives the expression of genes required for differentia-
tion (and not for pluripotency) but this pathway is somehow
blocked in ESCs by the conflicting effects of other genes (e.g.,
Nanog, Klf4, etc.) that attempt to promote differentiation along
different pathways (Loh and Lim, 2011). One line of evidence
purported to support this idea is that overexpression of Oct4,
like its removal, causes ESCs to differentiate (Niwa et al., 2000).
Here, we study Oct4 derivatives designed to act exclusively as
activators or repressors of transcription. Each protein bears the
PouV DNA-recognition sequence fused to either a strong tran-
scriptional activation region (VP16 and derivatives thereof) or
a strong repression region (Engrailed or HP1). We find that the
activator, but not the repressor, fusions (along with other tran-
scription factors) drive iPSC formation. The activator fusions,
but not the repressor fusions, maintain the growth and pluripo-
tency of murine ESCs lacking wild-type Oct4, and the activator
fusions uniquely block differentiation of multipotent progenitor
cells in Xenopus embryos. While maintaining ESCs in place of
Oct4, an Oct4-activator fusion can render the pluripotent state
both LIF-independent and immune to an ‘‘overexpression’’
phenotype (apparently by strongly activating key genes). We
suggest that the activity of Oct4 as an activator is sufficient for100 Cell Reports 1, 99–109, February 23, 2012 ª2012 The Authorsthe induction of iPSC formation and the maintenance of ESCs
and embryonic progenitors.RESULTS
Converting PouV Proteins to Activators and Repressors
Table 1 shows a series of fusion proteins, each with the DNA-
binding specificity of Oct4 or Xlpou91, designed to work exclu-
sively as activators or as repressors. Genes encoding these
proteins were constructed by fusing intact murine and human
Oct4 and Xlpou91 sequences, separately, to an activating region
derived from mammalian VP16; to the repressing region of the
Drosophila protein Engrailed (EnR); and to the mammalian
heterochromatin protein HP1. In some cases the flexible hinge
region of lambda C1 was interposed between the PouV protein
and attached regulatory regions, an approach that has been
particularly effective at converting full-length homeodomain
repressors to activators (Brickman et al., 2001; Brickman et al.,
2000; Zamparini et al., 2006). As a control, we also made fusions
in which the DNA-binding domain was damaged by the mutation
V267P (Niwa et al., 2002). We tested the activities of these fusion
proteins with reporters introduced into the previously described
murine ESC line ZHBTc4 (Niwa et al., 2000). Both endogenous
copies of Oct4 have been deleted from these cells, and an
Oct4 transgene, under control of a tetracycline (Tc)-repressible
promoter, has been added. The cells grow as ESCs in the
absence of Tc, and addition of Tc causes them to differentiate
into trophoblast and primitive endoderm cells. In the absence
of Tc, an introduced reporter gene bearing Oct4 binding sites
is expressed, but by 24 hr after the addition of Tc, the introduced
reporter fails to be expressed. mRNA and protein measurements
confirm that the added Oct4 gene was essentially silent at this
time. Within 96 hr after the addition of Tc, the cells have differen-
tiated (Morrison and Brickman, 2006; Niwa et al., 2002; Niwa
et al., 2000).
We cotransfected ZHBTc4 ESCs 24 hr after the addition of Tc
with, separately, one of two different Oct4 responsive reporter
genes (Niwa et al., 2002) and one or another of the Pou proteins
listed in Table 1. One reporter contains the Oct4- and Sox2-
dependent enhancer of the Fgf4 gene driving the TK promoter,
and the other reporter contains six copies of a reiterated oc-
tamer-binding site. Both Oct4lVP2 and Xlpou91lVP2 efficiently
activated both reporters, whereas Oct4lEnR and Xlpou91lEnR
repressed basal expression. The fusion proteins neither acti-
vated nor repressed transcription from a reporter lacking any
PouV protein-responsive elements. lVP2 and lEnR had little
activity when fused to Oct4V267P (Niwa et al., 2002) (Figure S1).
Activator Fusion Proteins Block Differentiation In Vivo
We injected mRNA encoding Xlpou91, Xlpou91lEnR, or
Xlpou91lVP2 into early Xenopus embryos and assessed, by
in situ hybridization and RT-PCR, the expression of early lineage
markers at gastrulation. We found that markers of early meso-
derm and endoderm differentiation (Sox17, Mixer, and Goose-
coid [Gsc]) were suppressed by Xlpou91 and Xlpou91lVP2
and were enhanced by Xlpou91lEnR. In contrast, the ventral
marker BMP4, whose activity has been linked to ESC self-
renewal (Morrison and Brickman, 2006; Ying et al., 2003), re-
sponded oppositely to these added factors (Figures 1A and
S2A). The capacity of Xlpou91lEnR to induce the expression
of differentiation markers implies that their induction is an indi-
rect effect of inhibiting the PouV-supported network of undiffer-
entiated gene expression.
Activator Fusion Proteins Rescue Oct4 Null ESCs
Figure 1B shows that exogenously added Xlpou91lVP2 and
Oct4lVP2 maintained ZHBTc4 ESC growth in the absence of
endogenous Oct4 (i.e., in the presence of Tc), whereas neither
of the repressor fusions did so. The colonies depicted in the
figure were generated by stable transfection of the ZHBTc4
ESCs with vectors expressing both the Pac gene (which renders
cells resistant to puromycin) and one or another wild-type PouV
proteins or PouV fusion protein under the control of the strong
constitutive CAG promoter. The efficiency with which Oct4lVP2
supported Oct4 null ESCs (the rescue index, or normalized
rescue efficiency) (Niwa et al., 2002) was equivalent to that
obtained with wild-type Oct4. Although the rescue index for
Xlpou91lVP2 was not as high as that obtained by Oct4lVP2,
both proteins supported identical undifferentiated colony
morphologies. Inspection of the rescued colonies suggests
that Oct4lVP2 and Xlpou91lVP2 rendered the cells less likely
to spontaneously differentiate than those rescued by wild-type
Oct4 or Xlpou91. Thus, the latter displayed typical ESC colony
morphology, with undifferentiated cells in the center and differ-
entiated cells around the periphery (Figure 1C). In contrast,
colonies rescued by the activator fusion proteins appeared
undifferentiated throughout (Figure 1D). The mutant Oct4V267P,
fused to either lVP2 or lEnR, was unable to support growth in
the absence of Oct4 (Figure S2B). We also noted that colonies
derived from stable transfection of ZHBTc4 with Oct4 or
Xlpou91, in the absence of Tc, contained more differentiated
cells than those in the presence of Tc (Figure 1C). This phenotype
is consistent with the observation that overexpression (as well asunderexpression) of Oct4 induces differentiation (Niwa et al.,
2000). However, colonies derived from transfection of the
activator forms of both proteins remained completely undifferen-
tiated in the absence of Tc, a matter we return to below. Trans-
fection of Oct4lEnR and Xlpou91lEnR into Oct4-expressing
cells produced colonies composed largely of differentiated cells,
as expected (Figure 1E). Similar completely undifferentiated
colony morphologies were observed when Oct4lVP2 was intro-
duced into the unrelated E14Tg2A ESC line (Figure S2C).
We further substantiated the rescue experiment just described
by generating ZHBTc4 cell lines maintained by wild-type Oct4
and, separately, by Oct4lVP2 and by Xlpou91lVP2. Colonies
like those in Figures 1C and 1D were expanded for at least five
passages in the presence of constant puromycin and Tc. The
Oct4lVP2- and Xlpou91lVP2-supported cultures had fewer
differentiated cells than did those supported by wild-type Oct4
(Figure S4A). In both cases we examined multiple independent
clonal cell lines to assure that ESC phenotypes were not the
result of isolated karyotypic changes. As Oct4lVP2 and
Xlpou91lVP2- expressing cell lines appeared identical, we
focused on Oct4lVP2-supported cell lines. Four different
Oct4lVP2-supported cell lines were also confirmed to have
normal karyotypes (data not shown). We found that these cell
lines self-renewed as efficiently as Oct4-supported lines, as as-
sayed by assessment of the capacity of single cells to generate
ESC colonies (Figures S4B and S4C). No difference in prolifera-
tion or plating efficiency was detected when these lines were
compared to either ZHBTc4 or the unrelated ESC line
E14Tg2A (Figure S4D). ESCs supported by Oct4lVP2, like
ZHBTc4 and E14Tg2A cells, expressed the ESC transcription
factors Nanog, Sox2, and Oct4 and the cell-surface markers
SSEA-1 and E-cadherin (Figure 3B, S4E, and S4F).
Activator Fusion Proteins Induce Pluripotency
As noted in the Introduction, Oct4 is typically required, alongwith
other transcription factors, to induce reprogramming of somatic
cells to iPSCs in vitro. We tested the ability of various PouV-acti-
vator fusions and -repressor fusions to substitute for wild-type
Oct4 in such a reprogramming experiment. We were able to
generate both human and murine stable iPSCs by using acti-
vator, but not, where tested, repressor fusions (Figures 2A and
2B). The mouse iPSCs in Figure 2A were generated with the
use of a single piggyBac transposon that bears the Sox2, Klf4,
and c-Myc genes, as well as either wild-type Oct 4 or Oct4lVP2,
all under control of a Tc-inducible promoter (Kaji et al., 2009).
Although the timing of the appearance of ESC-like iPSC colonies
after transfection and addition of the Tc analog Doxycycline
(Dox) was comparable in the two cases, the Oct4lVP2 colonies
grew faster than did their counterparts containing wild-type Oct4
(Figure 2A). The Oct4lVP2-derived iPSC colonies were
expanded in the presence of Dox. As expected for iPSCs, growth
became independent of the exogenous genes, as indicated by
growth in the absence of Dox (Figures S5A and S5B). When
Oct4lVP2-induced iPSCs were transplanted into adult mice,
they formed teratomas containing derivatives of all three germ
layers (Figure S5C), a further indication of pluripotency. To
generate human iPSCs, we infected human fibroblasts with len-
tiviral vectors expressing the three additional factors (all human)Cell Reports 1, 99–109, February 23, 2012 ª2012 The Authors 101
Figure 1. Actions of PouV-Activator
and -Repressor Proteins
(A) In situ assays for the mRNA products of Mixer,
Sox17, and BMP4 were performed on stage 10.25
embryos after injection of Xlpou91, Xlpou91lVP2,
or Xlpou91lEnR mRNA at the two-cell stage into
both blastomeres. The images are from the
vegetal pole (top two rows) and the animal pole
(bottom row).
(B) The relative numbers of cells rescued by the
indicated regulators is shown as the rescue index.
Each transfection was divided, and half the cells
were plated in the presence of Tc and the rest in its
absence. The rescue index was calculated by
dividing the number of alkaline phosphatase (AP)-
positive colonies obtained in the absence and
presence of Oct4 (± Tc). Data represent the mean
values obtained from three independent experi-
ments.
(C–E) Morphology of ESC colonies supported by
wild-type PouV proteins (C), activator fusions (D),
and repressor fusions (E). The colonies were
generated by stable transfection of the ZHBTc4
ESCs with vectors expressing one or another wild-
type PouV or PouV fusion proteins and the Pac
gene (which renders cells puromycin resistant)
from an internal ribosome entry site (IRES) in the
same message, all under the control of the strong
CAG promoter. Constitutive expression of the
exogenous fusion proteins in the absence of Oct4
was selected on the basis of Puromycin resistance
in the presence of Tc. Cultures were stained for
AP (red).plus either wild-type human OCT4 or OCT4 fusion proteins
(Figure S3) (Papapetrou et al., 2009). Figure 2B shows that three
OCT4-repressing fusions eliminated iPSC formation and that
two activating fusions labeled ‘‘weak’’ and ‘‘medium’’ (see
Table 1 legend) substituted efficiently for wild-type OCT4. The
activator fusion labeled ‘‘strong’’ worked somewhat less effi-
ciently than did its weaker counterparts, but Figure 2C shows102 Cell Reports 1, 99–109, February 23, 2012 ª2012 The Authorsthat decreasing its concentration
improved its activity in this assay. Thus,
Oct4-activator fusions, but not -repressor
fusions, promote iPSC formation.
Gene Expression in Activator-
Induced and -Maintained
Pluripotent Cell Lines
Murine ESC Lines
We used microarrays to compare the
transcriptional profiles of ESCs main-
tained, respectively, by wild-type Oct4
and by Oct4lVP2. A set of genes directly
or indirectly responsive to wild-type Oct4
was previously determined by measuring
changes in gene expression after knock-
down of endogenous Oct4 (by adding Tc
to the parental ZHBTc4 ESCs) (Sharov
et al., 2008). Putative direct targets ofOct4, from among these genes, were identified as being rapidly
responsive and having at least one Oct4 binding site in the
vicinity of the transcription start site on the basis of the ChIP-
PET method. Of the 372 putative Oct4-dependent targets
(from Sharov et al., 2008), some 94% were expressed at normal
or higher levels in Oct4lVP2- maintained cells. Expression of the
remaining 6% (23 genes) was reduced more than 2-fold
Figure 2. Oct4-Activator Fusions Support iPSC Generation
(A) Morphology of colonies resulting from mouse embryonic fibroblasts (MEF)
transfection with either wild-type Oct4 or Oct4lVP2 alongside the other re-
programming factors (cMyc, Klf4, and Sox2) at days 5, 9, 18, and 24 after
transfection in the presence of the Tc analog Dox. MEFs were transfected with
a piggyBac transposon bearing a single-message multigene expression
cassette under the control of a Tc-inducible promoter.
(B) OCT4 activator fusions support human iPSC generation. MRC-5 human
embryonic fibroblasts were transduced with combinations of four lentiviral
bicistronic vectors coexpressing each reprogramming factor, linked by a P2A
peptide, to a fluorescent protein (Papapetrou et al., 2009): SOX2 together with
mCitrine, KLF4 with mCherry, cMYC with mCerulean, and either wild-type
OCT4 or OCT4 fusion proteins with vexGFP. The efficiency was calculated
with the use of the experimental setup depicted in Figure S3C. In brief, the
number of Tra-1-81+ colonies (scored by immunostaining on day 15 after
transduction) per number of plated cells divided by the fraction of quadruple
positive cells as estimated by flow cytometry on day 2 after transduction.
(C) Lower levels of the strong activator (OCT4-VP16 [3F]) work more efficiently
in iPSC formation. MRC-5 human embryonic fibroblasts were transduced as in
(B) with the use of 3-fold titrations of the vector expressing either wild-type
OCT4 or OCT4-VP16 (3F) and constant amounts of the other three vectors
(SOX2, KLF4, cMYC). The reprogramming efficiency was calculated as in (B).
See also Figure S3C and its associated legend.(Figure 3A). Among these 23 there were only two genes with
known pluripotency-related activity: Sall4 and Lefty1. Most
genes associated with differentiation (e.g., Cdx2, Eomes, Fgf5,
Gata6, Gata3, Igf2, Hand1, Esx1) were either reduced or
expressed at normal levels (Table S1). All other pluripotency-
related genes were expressed at either normal or higher levels
in Oct4lVP2-rescued cells (Table S1, Figure 3B; also see Fig-
ure S7), with a small set of primordial germ cell and pluripotency
markers expressed at levels greater than 2-fold above wild-type
cells, including Gdf3, Dppa2, Dppa3 (Stella), Eras, Tcfcp2l1, Id3,
Fbxo15, Sox15, andNanog. Nanogwas expressed at an average
of 2- to 5-fold higher than in ordinary ESCs, and its distribution
was more homogeneous (Figure S4E). Gene ontology (GO)
annotations of the upregulated and downregulated genes in
the Oct4lVP2 cell line with more than 2-fold changes are listed
in Table S2. While there does not appear to be a single biological
process common to the upregulated genes in Oct4lVP2 cells,
the downregulated gene set was enriched in functions associ-
ated with embryonic development and differentiation. These
GO terms include a list of developmental transcription factors,
cell differentiation, system development, epithelial differentia-
tion, sex differentiation, cell migration,Wnt signaling, and several
categories related to neural development.
Murine and Human iPSC Lines
Endogenous pluripotency genes, includingOct4, Klf4, Sox2, and
c-Myc, were expressed in murine iPSCs generated from fibro-
blasts with Oct4lVP2 (plus the other three factors) (Figure 3C,
Figure S5). Expression of Nanog and Dppa4 at early times after
transduction of human fibroblasts with OCT4 fusions was
increased by increasingly stronger versions of OCT4-VP16 (Fig-
ure 3D). These markers were only modestly induced at this early
time point by wild-type OCT4, and not at all by OCT4-HP1.
ESCs Rescued and Maintained by Activator Fusions
Are Resistant to Differentiation
Overexpression of Nanog has been reported to counter the
induction of differentiation as a result of LIF removal (Chambers
et al., 2003). Consistent with these findings, our Oct4lVP2-sup-
portedmurine ESCs, which overexpress Nanog, are able to grow
in the absence of LIF, as shown in Figure 4A. Oct4lVP2-main-
tained ESC lines were AP positive and exhibited undifferentiated
ESC morphology when grown with or without LIF. These cells
did, however, grow more slowly in the absence of LIF than in
its presence (Figure 4 and Figures S6B and S6C). To better
understand the response of Oct4lVP2-supported cells to LIF,
we compared mRNA from Oct4lVP2-rescued cell lines and
two sets of control lines (Oct4-rescued and the parental ZHBTc4
cells) in response to LIF withdrawal (Figures 4B and 4C, Table
S3, and Figure S6). LIF withdrawal caused similar changes in
gene expression in the latter two lines, with a single set of
genes decreased (cluster a, Figure 4B) and a second set
increased (cluster b, Figure 4B). However, LIF withdrawal from
Oct4lVP2-maintained cell lines caused little change in expres-
sion of genes in either set. For example, expression of the plurip-
otency genes Nanog, Klf4, Sox2, and Rex1 was downregulated
in the control cells after LIF withdrawal, but their expression
was unaffected in Oct4lVP2-maintained cells. The endodermal
markers Gata4 and Gata6, upregulated upon LIF withdrawalCell Reports 1, 99–109, February 23, 2012 ª2012 The Authors 103
Figure 3. Oct4 Activator Fusions Induce and Maintain the Expression of Pluripotency-Related Genes
(A) Oct4lVP2 enhances the expression of Oct4-positively-regulated genes and inhibits the expression of those genes negatively regulated by Oct4.
We compared the total set of genes changing when Oct4lVP2-supported cells were compared to controls, to the complete set of genes responsive to Oct4.
Themajority of these genes (94%) were expressed at normal (around the x axis) or higher than normal (above the x axis) levels in Oct4lVP2 cells. The basis for this
plot was the difference between the log expression of genes in Oct4lVP2 cells and the average log expression in both controls, plotted against the maximum
gene expression change (log ratio) in a time course afterOct4-Tc silencing (addition of Tc) in ZHBTc4 ESCs (the time course data from Sharov et al., 2008). Genes
with < 1.5-fold change of expression after Oct4-Tc silencing are not shown. Oct4-dependent genes that also contain Oct4, Nanog, and Sox2 binding sites are
indicated as targets (light blue or purple; see Sharov et al., 2008).
(B) Expression of pluripotency genes in Oct4lVP2-rescued cells. Expression levels of pluripotency-related genes including Nanog, Sox2, Klf4, and Rex1 were
determined by qRT-PCR. Expression levels of all analyzed genes were normalized to TBP levels for each sample.
(C) iPSCs generated with the use of Oct4lVP2 express levels of pluripotency markers similar to those of normal iPSCs. Expression levels of a range of pluripotent
cell markers were assessed by qRT-PCR. Nanog, Fgf4, Rex1, Dppa4, and Eras expression is shown in wild-type Oct4 and Oct4lVP2 iPSCs. Duplicate bars
represent independent iPSC lines. Expression levels were normalized to TBP levels for each sample. Key indicates the Oct4 protein used for reprogramming. E14
(embryonic day 14) Tg2A ESCs and MEFs were used for the sake of comparison.
(D) Wild-type OCT4 and its activator fusions, but not OCT4-HP1 repressor fusions, induce immediate early expression of pluripotency markers, NANOG and
DPPA4. MRC5 human embryonic fibroblast cells were harvested 48 hr after viral transduction for mRNA analysis. Expression levels in an iPSC line generated with
the use of wild-type forms of all four factors are shown for comparison. Levels of gene expression are relative to RPL7 and normalized to nontransduced control.
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Figure 4. Differential Effect of Oct4lVP2 Dose on ESC Differentiation
(A) Oct4lVP2 maintains undifferentiated phenotypes irrespective of the presence of LIF or additional Oct4. Oct4lVP2-supported and control ESC lines were
plated in the absence of LIF or absence of Tc (Oct4 overexpression) for 5 days. Cultures were stained for AP (red).
(B) Changes in gene expression normally associated with LIF withdrawal do not occur in Oct4lVP2-supported cells. Here, a heat map shows the 3,000 genes with
the most significant differences in gene expression after LIF withdrawal. Two clusters are bracketed by ‘‘a’’ and ‘‘b’’: a, genes that are downregulated in Oct4 and
ZHBTc4 cells, but not in Oct4lVP2 cells, after 120 hr of LIF withdrawal; b, genes that are upregulated in Oct4 and ZHBTc4 cells, but not in Oct4lVP2 cells, after
120 hr of LIF withdrawal.
(C) Pluripotency genes are supported in the absence of LIF inOct4lVP2 cells. Shown are plots comparingmean log intensity values of representative pluripotency
genes. Error bars represent SD between expression levels in two independent clones.
(D) Oct4lVP2* cells compared to original Oct4lVP2 and control cell lines. These cells, generated in reduced puromycin, express reduced levels of Oct4lVP2 and
Nanog. Western blots comparing expression levels of Oct4 and Nanog in the different rescued cell lines are shown.
(E) Oct4lVP2* cell lines differentiate in response to LIF withdrawal and Oct4 overexpression. Cells were plated at clonal density in the absence of LIF or Oct4
overexpression for 5 days. Two clones for each cell line except ZHBTc4 were used and stained for AP activity (red). Representative colonies are shown for each
condition.from typical ESCs, remained unaffected by LIF withdrawal from
Oct4lVP2-supported ESCs. Expression of certain mesoderm
markers that are normally expressed alongside Oct4 in the
primitive streak (e.g., Brachyury and Wnt 3) were increased after
LIF removal from Oct4lVP2-supported cells (Figure 4C and
Figure S7). When examined globally, there was a striking nega-
tive correlation between the set of genes that normally respond
to LIF and those expressed at high levels in Oct4lVP2-main-
tained cells grown in the absence of LIF (comparison based on
average log ratio, r = 0.695, t = 153, p < 0.0001; also see
Figure S6G).
Despite the robust expression of Nanog and other pluripo-
tency-related genes in Oct4lVP2-maintained ESCs, and the
conferred LIF independence just described, the expression
of Oct4lVP2 itself was 2- to 5-fold lower than that of Oct4
in ESCs maintained by wild type Oct4 (Figure 4D, Figure S4E).
We repeated the original Oct4lVP2-rescue experiment togenerate new stable cell lines (see Figure S4A), adding the
same amount of Tc to the medium but a reduced amount of
puromycin. This reduced stringency of selection enabled the
isolation of new Oct4lVP2-supported cell lines (Oct4lVP2*),
which expressed even lower levels (from 1.4- to 2-fold
mRNA and/or protein) of Oct4lVP2 (Figure 4D). These lines
also express correspondingly lower levels of Nanog and other
pluripotency factors, similar to levels found in ESCs and in
cells rescued by Oct4 (Figure 4D, Figures S8C and S8D).
Upon removal of LIF, these cells differentiated to extents
similar to those of wild-type Oct4-rescued ESCs and parental
ZHBTc4 control cell lines (Figure 4E). Colonies generated
from clonal growth of Oct4lVP2* cell lines appeared similar
to wild-type Oct4-supported cell lines, both forming differenti-
ated cells at the periphery (Figures S8A and S8B) and both
sensitive to the differentiation-induced effect of Oct4 overex-
pression (Figure 4E).Cell Reports 1, 99–109, February 23, 2012 ª2012 The Authors 105
DISCUSSION
Our findings support the idea that the necessary and sufficient
action of Oct4 in inducing iPSC formation, and in blocking differ-
entiation in vitro and in vivo, is to directly activate (rather than
directly repress) expression of specific target genes. Thus, in
both mouse ESCs and Xenopus embryos, PouV/Oct4-repressor
fusion proteins induced differentiation, whereas the activator
forms maintained the undifferentiated pluripotent state. Our
results are consistent with a ‘‘positive only’’ model (based on
a different line of experimentation) for maintenance of pluripo-
tency of ESCs (Chamberlain et al., 2008).
Moreover, the Oct4-activator fusions, but not the -repressor
fusions (along with additional transcription factors), induced
iPSC formation. Analysis of gene expression profiles revealed
that Oct4-activator fusions specifically enhanced expression of
many genes identified as required for pluripotency, but not of
genes that drive differentiation. One of our ESC lines (see below)
maintains its ESC state even after withdrawal of LIF. These cells
do not differentiate in response to additional Oct4 and thus do
not display the usual Oct4 overexpression phenotype. These
results are consistent with recent reports that claim enhanced
efficiency in reprogramming as a result of the use of Oct4-
VP16, Sox2-VP16, and Nanog-VP16 fusion proteins (Wang
et al., 2011a) or Oct4-MyoD (Hirai et al., 2011).
We cannot exclude the possibility that Oct4 can repress
certain genes, particularly in cases where it may bind coopera-
tively with other pluripotency factors with repression activity,
and this might also explain its association with corepressor
complexes. Such an activity, were it to exist, would not under-
mine the central finding of this paper, namely that activation
and not repression is sufficient to induce and maintain the
undifferentiated state. It is highly unlikely that our Oct4-VP16
fusion can repress certain genes as it activates others. The
fusion activates two reporters bearing two different Oct4
DNA-recognition elements, both derived from natural enhancer
elements. Moreover, we found that the activator fusion acti-
vated transcription of Xist, putatively a gene repressed by
Oct4 in vivo (Navarro et al., 2008) (Table S1). These and other
observations indicate that the fusion protein Oct4lVP2 is likely
an activator of all Oct4 targets, or at least of all those required
for pluripotency.
Our work contrasts with the suggestion of Loh and Lim (2011)
that, in maintaining the ESC state, Oct4 attempts to drive differ-
entiation along a specific path (see Introduction). It would also
contradict the notion that an essential role of Oct4 in maintaining
pluripotency is to directly repress genes required for differentia-
tion (Bilodeau et al., 2009; Boyer et al., 2005; Boyer et al., 2006;
Chen et al., 2008; Kim et al., 2008; Loh et al., 2006; Pasini et al.,
2010). It would, however, be consistent with the suggestion of
Ying et al. (2008) that pluripotency is a ‘‘ground state’’ main-
tained by factors that prevent differentiation in response to (for
example) paracrine signaling. Genes activated by Oct4 (and
perhaps other pluripotency factors) would perform this function.
This picture would cast pluripotency as another example of a
‘‘differentiated’’ state maintained by positive feedback. Thus,
for other cases of terminal differentiation, an activator (or groups
of self-reinforcing activators) maintains expression of its own106 Cell Reports 1, 99–109, February 23, 2012 ª2012 The Authorsgene as it activates expression of genes required for the differen-
tiated state (Hobert, 2008). Oct4 is widely believed tomaintain its
own expression in a feedback loop involving, perhaps, other
pluripotency gene regulators (Chew et al., 2005; Hall et al.,
2009; Sharov et al., 2008). We found that increasing the acti-
vating region strength of the Oct4 fusions (bearing VP16 deriva-
tives), as well as increasing the concentration of one of them,
resulted in higher levels of Nanog expression, suggesting that
Oct4 directly activates Nanog as part of this loop.
How, then, would we rationalize this proposal with findings
and models of others? First, we note the importance attributed
by Loh and Lim (2011) to the finding that overexpression of
Oct4 causes differentiation, a result taken to imply that Oct4 acti-
vates genes required for differentiation, not for pluripotency. But
overexpression experiments can be difficult to interpret. An acti-
vator works in a concentration-dependent manner, binding to
proper DNA sites (usually with other proteins) over a certain
concentration range and then, at higher concentrations, binding
less specifically to DNA. And, by virtue of protein-protein interac-
tions, an overexpressed activator can inhibit (squelch) the effect
of other activators and even its own action (Gill and Ptashne,
1988; Ptashne, 2009). Indeed, it has been reported that overex-
pression of Oct4 lacking a functional DNA-binding domain
induces ESCs to differentiate (Niwa et al., 2002), a result indi-
cating that the phenotype is not directly attributable to the ordi-
nary action of Oct4.
In our experiments, any side effects of overexpression
evidently have been eliminated by the use of the strong activator
fusions. Thus, in a line of ESCs maintained by Oct4lVP2, the
level of the Oct4lVP2 protein is low, significantly lower than
that of wild-type Oct4 found in the typical ESC. These cells
express high levels of select pluripotency factors, including
Nanog, and are resistant to the ordinary inducing effect of differ-
entiation upon LIF removal. These cells also, unlike ESCs main-
tained by exogenously added Oct4, do not differentiate when
additional Oct4 is expressed. Another line, selected to express
even lower levels of the activator, behaves like a typical ESC,
subject to differentiation upon LIF removal, despite the very
low level of expression of the activator fusion, and this line differ-
entiates upon expression of additional Oct4.
Second, we note the importance given to genome-wide ChIP
experiments showing that, in ESCs, Oct4 can be found bound to
regulatory elements at certain genes that are not expressed—
these genes become expressed upon differentiation. But lacking
further analysis, these purported facts do not show that Oct4 is
working as a repressor at those genes. Perhaps Oct4 is bound
to genes in a nonfunctional state, awaiting relief from, or addition
of, some partner to work. Polycomb, for example, is found at
many silent genes in ESCs, but its removal has little effect on
the maintenance of pluripotent gene expression (Schoeftner
et al., 2006), and there are indications that polycomb remains
at these genes during very early steps in differentiation (J.M.B.
and W.A. Bickmore, unpublished data). There may be
a misleading assumption at work here, namely that for a gene
to be ‘‘off’’ it must be actively repressed. Though this is true for
most genes in bacteria, it is not true in general for genes
in eukaryotes. In bacteria, specific repressors are required to
eliminate an otherwise significant basal level expression upon
removal of activators, but this is evidently not true for eukaryotic
genes. Rather, it seems, the general inhibiting effect of nucleo-
somes maintains basal expression at very low levels (Struhl,
1999; Wang et al., 2011b). Thus, without activators that would
turn on the differentiation genes, there would be no need for
repressors to turn them off. And so in ESCs, where activators
maintain expression of pluripotency genes, differentiation genes
could simply be off (by default, as it were) until activated by some
activators that are rendered functional by virtue of gain (or loss)
of a signal.EXPERIMENTAL PROCEDURES
ESCs were cultured on 0.1% gelatin-coated flasks or plates (IWAKI) in Glas-
gow modified Eagle’s medium (GIBCO) containing nonessential amino acids,
glutamine, sodium pyruvate, 0.1 mM mercaptoethanol, 10% fetal calf serum
(FCS), and LIF as described previously (Livigni et al., 2009; Morrison and Brick-
man, 2006). LIF withdrawal and Oct4 overexpression was performed accord-
ing to Morrison and Brickman (2006). For ESC self-renewal rescue experi-
ments, 2 3 107 ZHBTc4 ESCs were electroporated with 100 mg of linearized
plasmid DNA followed by culture with or without 2 mg/ml Tc (Sigma) for
2 days. Cells were then cultured in 2 mg/ml puromycin (Sigma) with or without
Tc for 7 days. The resulting colonieswere stained for alkaline phosphatase (AP)
activity (Sigma-Aldrich) or expanded as clonal lines (Morrison and Brickman,
2006). The cDNAs used for ESC rescue were inserted into pCAGIP vector
(Niwa et al., 2002; Niwa et al., 1991).
Luciferase assays were performed as described previously (Brickman et al.,
2001; Morrison and Brickman, 2006). ZHBTc4 ESCs (1 3 105) were plated on
a 24-well plate with 2 mg/ml of Tc. Twenty-four hours after plating, the reporter
and test plasmid were transfected with the use of Lipofactamine 2000 (Invitro-
gen). Twenty-four to forty-eight hours after transfection, the cells were
collected and lysed, and luciferase assay was performed with the Dual-Lucif-
erase Reporter Assay System (Promega). Reporter plasmids were a kind gift
from Professor Hitoshi Niwa (Riken Institute, Japan) (Niwa et al., 2002). The
expression vector used was the pCAG-IP plasmid.
Growth rates were assessed in 96-well plates with CellTiter 96 Aqueous One
Solution Cell Proliferation Assay (Promega). A total of 1,000 cells were plated
per well and assayed every 24 hr according to the manufacturer’s instructions.
AP staining was performedwith the Leukocyte Alkaline Phosphatase Assay Kit
(Sigma).
For antibody staining, cells were washed twice in PBS, followed by fixation
in 4%paraformaldehyde. Cells were then permeabilized in PBS + 0.1% Tween
20 (PBST), and blocking was performed by adding 1% bovine serum albumin
(BSA) (Sigma) PBST to the cells for 30 min at room temperature. Primary anti-
bodies (see Table S4 for details) were incubated overnight at 4C, followed by
three washes in PBST for 10min each. Alexa Fluor-conjugated secondary anti-
bodies (see Table S4 for details) were diluted in blocking solution and added to
the cells for 3 hr at room temperature with the DAPI solution. Finally, cells were
washed three times in PBST.
Flow cytometry was used to analyze the percentage of ESC clones express-
ing the cell-surface markers SSEA1 and E-Cadherin (for the antibodies, see
Table S4). Cells were collected into the cell-dissociation buffer (GIBCO) and
incubated at 37C for 10 min. Single-cell suspension was achieved by gentle
repeated pipetting. After PBS washes, cells were resuspended in 500 ml FACS
buffer (13 PBS and 10% FCS). To mark apoptotic cells, 5 ml/106 cells of 7AAD
solution (BD PharMingen) was added to cells. Samples were analyzed in
a FACSCalibur flow cytometer (BD Biosciences). Data were analyzed with
the Cell Quest software (BD Biosciences).
For qRT-PCR analysis, total RNA was prepared from cells with the use of
Trizol reagent (Invitrogen). RNA (0.5–1 mg) was used as a template for cDNA
synthesis with the use of Superscript III (Invitrogen). qRT-PCR was performed
with the use of a LightCycler 480 (Roche). Primers and PCR conditions are
listed in Table S5.
Embryo injection, culture, and in situ hybridization were described in Zam-
parini et al., 2006 andMorrison andBrickman, 2006. To generate RNA for injec-tions, pCS2+ plasmids harboring the target cDNAs Xlpou91lVP2, Oct4lVP2,
Xlpou91lEnR, Oct4lEnR, Oct4, and Xlpou91 were linearized with BssHII and
used as a template for RNA synthesis with SP6 polymerase (Promega). Total
RNA was prepared from five embryos with the RNeasy Mini Kit (QIAGEN)
and DNase1 treatment. RNA (500 ng) was used as a template for cDNA
synthesis with Superscript III (QIAGEN). Real-time PCR was carried out with
a Lightcycler 480 (Roche). Real-time PCR primers are listed in Table S5.
For microarray analysis, two independent clones from each cell line were
used as biological replications. Cy3-CTP-labeled sample targets were
prepared from 2.5 mg of total RNAwith the use of a Low RNA Input Fluorescent
Linear Amplification Kit (Agilent). Cy5-CTP-labeled reference target was
produced from 2.5 mg of Stratagene Universal Mouse Reference RNA. Purified
target RNAs were hybridized to the NIA Mouse 44K Microarray version 3.0
(whole-genome 60-mer oligo arrays, Agilent Technology, design ID 015087)
(Carter et al., 2005) according to the manufacturer’s protocol (Two-Color
Microarray-Based Gene Expression Analysis Protocol, version 5.0.1). Data
were analyzed via NIA Array Analysis (Sharov et al., 2005) under standard
statistical conditions (FDR < 0.05, 2-fold expression level change).
For mouse iPSC generation, PiggyBac transposons containing Oct4 and
Oct4lVP2 were constructed as described previously (Kaji et al., 2009). Mouse
embryonic fibroblasts (MEFs) were isolated from 13.5 dpc (days postcoitus)
ROSA26 knockin rtTA-IRES-GFP embryos. MEF Nucleofector Kit 2 (Amaxa)
and program T-20 were used for nucleofection. A total of 2 3 106 cells were
transfected, and 53 105 cells were seeded on gelatine in 10 cm2 dishes. Cells
were cultured in ESCmedia supplemented with 1.5 ug of Dox. Colonies arising
after transfection were picked at day 24, trypsinized, and replated on gelatine.
Dox was removed from the culture after several passages.
Lentiviral vector production, human iPSC generation, and immunostaining
were performed as previously described (Papapetrou et al., 2009). Separate
lentiviral constructs encoding full-length human Oct4, Sox2, Klf4, and cMyc
linked by a P2A peptide to vexGFP, mCitrine, mCherry, and mCerulean,
respectively, were used. MRC-5 human embryonic fibroblasts (American
Type Culture Collection [ATCC]) were transduced with supernatants of the
four lentiviral vectors in the presence of 4 mg/ml polybrene for approximately
16 hr. Three days after transduction, the cells were plated at a density of
20,000 cells per 60 mm dish on a feeder layer of mitomycin-C-treated MEFs.
Analysis of the four vector-encoded transcription factors’ expression by flow
cytometry 3 days after transduction was used to identify groups with similar
expression levels (mean fluorescence intensity) for comparison. The
next day, the medium was switched to hESC medium supplemented with
6 ng/mL FGF2 and was replaced every day thereafter. Then, 16-18 days after
transduction, colonies with hESC morphology were mechanically dissociated
and transferred into 24-well plates on MEFs. Cells were thereafter passaged
with dispase and expanded to establish hiPSC lines.
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